• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD137 及其配体的双向信号转导调控炎症

Regulation of Inflammation by Bidirectional Signaling through CD137 and Its Ligand.

机构信息

School of Biological Sciences, University of Ulsan, Ulsan 680-749, Korea.

出版信息

Immune Netw. 2012 Oct;12(5):176-80. doi: 10.4110/in.2012.12.5.176. Epub 2012 Oct 31.

DOI:10.4110/in.2012.12.5.176
PMID:23213310
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3509161/
Abstract

Although the majority of research on CD137 has been directed to T cells, it is becoming clear that this molecule has distinct functions in other lineages of cells, including non-hematopoietic cells. In particular, emerging evidence suggests that the CD137-its ligand (CD137L) network involving immune cells and non-immune cells, directly or indirectly regulates inflammation in both positive and negative manners. Bidirectional signaling through both CD137 and CD137L is critical in the evolution of inflammation: 1) CD137L signaling plays an indispensible role in the activation and recruitment of neutrophils by inducing the production of proinflammatory cytokines and chemokines in hematopoietic and non-hematopoietic cells such as macrophages, endothelial cells and epithelial cells; 2) CD137 signaling in NK cells and T cells is required for their activation and can influence other cells participating in inflammation via either their production of proinflammatory cytokines or engagement of CD137L by their cell surface CD137: 3) CD137 signaling can suppress inflammation by controlling regulatory activities of dendritic cells and regulatory T cells. As recognition grows of the role of dysregulated CD137 or CD137L stimulation in inflammatory diseases, significant efforts will be needed to develop antagonists to CD137 or CD137L.

摘要

虽然 CD137 的大多数研究都集中在 T 细胞上,但越来越明显的是,该分子在其他细胞谱系中具有独特的功能,包括非造血细胞。特别是,新出现的证据表明,CD137-CD137L 网络涉及免疫细胞和非免疫细胞,直接或间接地以正负两种方式调节炎症。CD137 和 CD137L 的双向信号对于炎症的发展至关重要:1)CD137L 信号通过诱导造血和非造血细胞(如巨噬细胞、内皮细胞和上皮细胞)中促炎细胞因子和趋化因子的产生,在中性粒细胞的激活和募集中发挥不可或缺的作用;2)NK 细胞和 T 细胞中的 CD137 信号对于其激活是必需的,并且可以通过其产生促炎细胞因子或其细胞表面 CD137 与 CD137L 的结合来影响参与炎症的其他细胞;3)CD137 信号可以通过控制树突状细胞和调节性 T 细胞的调节活性来抑制炎症。随着人们对失调的 CD137 或 CD137L 刺激在炎症性疾病中的作用的认识不断加深,将需要做出巨大努力来开发针对 CD137 或 CD137L 的拮抗剂。

相似文献

1
Regulation of Inflammation by Bidirectional Signaling through CD137 and Its Ligand.CD137 及其配体的双向信号转导调控炎症
Immune Netw. 2012 Oct;12(5):176-80. doi: 10.4110/in.2012.12.5.176. Epub 2012 Oct 31.
2
CD137-CD137 Ligand Interactions in Inflammation.CD137-CD137 Ligand 相互作用与炎症。
Immune Netw. 2009 Jun;9(3):84-9. doi: 10.4110/in.2009.9.3.84. Epub 2009 Jun 30.
3
Reverse signaling through the co-stimulatory ligand, CD137L, as a critical mediator of sterile inflammation.通过共刺激配体 CD137L 进行反向信号转导,作为无菌性炎症的关键介质。
Mol Cells. 2012 Jun;33(6):533-7. doi: 10.1007/s10059-012-0077-3. Epub 2012 Apr 20.
4
Role of the CD137 ligand (CD137L) signaling pathway during Mycobacterium tuberculosis infection.结核分枝杆菌感染过程中 CD137 配体(CD137L)信号通路的作用。
Immunobiology. 2014 Jan;219(1):78-86. doi: 10.1016/j.imbio.2013.08.009. Epub 2013 Aug 23.
5
Trogocytic CD137 transfer causes an internalization of CD137 ligand on murine APCs leading to reduced T cell costimulation.吞噬细胞性CD137转移导致小鼠抗原呈递细胞上CD137配体的内化,从而导致T细胞共刺激减少。
J Leukoc Biol. 2015 May;97(5):909-919. doi: 10.1189/jlb.3A0213-079RRR. Epub 2015 Mar 12.
6
CD137 ligand reverse signaling skews hematopoiesis towards myelopoiesis during aging.衰老过程中,CD137配体反向信号传导使造血向髓系造血倾斜。
Aging (Albany NY). 2013 Sep;5(9):643-52. doi: 10.18632/aging.100588.
7
CD137L-macrophage induce lymphatic endothelial cells autophagy to promote lymphangiogenesis in renal fibrosis.CD137L-巨噬细胞诱导淋巴管内皮细胞自噬促进肾纤维化中的淋巴管生成。
Int J Biol Sci. 2022 Jan 1;18(3):1171-1187. doi: 10.7150/ijbs.66781. eCollection 2022.
8
Recombinant TAT-CD137 Ligand Cytoplasmic Domain Fusion Protein Induces the Production of IL-6 and TNF-α in Peritoneal Macrophages.重组 TAT-CD137 配体胞质结构域融合蛋白诱导腹腔巨噬细胞产生 IL-6 和 TNF-α。
Immune Netw. 2011 Aug;11(4):216-22. doi: 10.4110/in.2011.11.4.216. Epub 2011 Aug 31.
9
Is CD137 Ligand (CD137L) Signaling a Fine Tuner of Immune Responses?CD137配体(CD137L)信号传导是免疫反应的微调器吗?
Immune Netw. 2015 Jun;15(3):121-4. doi: 10.4110/in.2015.15.3.121. Epub 2015 Jun 25.
10
Regulatory T Cells Inhibit T Cell Activity by Downregulating CD137 Ligand via CD137 Trogocytosis.调节性 T 细胞通过 CD137 胞吞作用下调 CD137 配体抑制 T 细胞活性。
Cells. 2021 Feb 9;10(2):353. doi: 10.3390/cells10020353.

引用本文的文献

1
Identification of a multi-omics factor predictive of long COVID in the IMPACC study.在IMPACC研究中鉴定出一种可预测长期新冠的多组学因素。
bioRxiv. 2025 Feb 14:2025.02.12.637926. doi: 10.1101/2025.02.12.637926.
2
CD137 Signaling Mediates Pulmonary Artery Endothelial Cell Proliferation Under Hypoxia By Regulating Mitochondrial Dynamics.CD137 信号通过调节线粒体动态在低氧下介导肺动脉内皮细胞增殖。
J Cardiovasc Transl Res. 2024 Aug;17(4):859-869. doi: 10.1007/s12265-024-10493-y. Epub 2024 Feb 12.
3
PRRSV-1 induced lung lesion is associated with an imbalance between costimulatory and coinhibitory immune checkpoints.

本文引用的文献

1
Cutting edge: 4-1BB controls regulatory activity in dendritic cells through promoting optimal expression of retinal dehydrogenase.前沿:4-1BB 通过促进视网膜脱氢酶的最佳表达来控制树突状细胞的调节活性。
J Immunol. 2012 Sep 15;189(6):2697-701. doi: 10.4049/jimmunol.1201248. Epub 2012 Aug 15.
2
Reverse signaling through the co-stimulatory ligand, CD137L, as a critical mediator of sterile inflammation.通过共刺激配体 CD137L 进行反向信号转导,作为无菌性炎症的关键介质。
Mol Cells. 2012 Jun;33(6):533-7. doi: 10.1007/s10059-012-0077-3. Epub 2012 Apr 20.
3
High levels of costimulatory receptors OX40 and 4-1BB characterize CD4+CD28null T cells in patients with acute coronary syndrome.
猪繁殖与呼吸综合征病毒1型(PRRSV-1)诱导的肺部病变与共刺激和共抑制免疫检查点之间的失衡有关。
Front Microbiol. 2023 Jan 12;13:1007523. doi: 10.3389/fmicb.2022.1007523. eCollection 2022.
4
The long and winding road: From mouse linkage studies to a novel human therapeutic pathway in type 1 diabetes.漫长曲折的道路:从鼠的连锁研究到 1 型糖尿病的新的人类治疗途径。
Front Immunol. 2022 Jul 22;13:918837. doi: 10.3389/fimmu.2022.918837. eCollection 2022.
5
The Micro-Immunotherapy Medicine 2LEID Exhibits an Immunostimulant Effect by Boosting Both Innate and Adaptive Immune Responses.微免疫治疗药物 2LEID 通过增强先天和适应性免疫反应发挥免疫刺激作用。
Int J Mol Sci. 2021 Dec 22;23(1):110. doi: 10.3390/ijms23010110.
6
Genetic Aberrations Associated with Photodynamic Therapy in Colorectal Cancer Cells.与结直肠癌细胞光动力疗法相关的遗传异常。
Int J Mol Sci. 2019 Jul 2;20(13):3254. doi: 10.3390/ijms20133254.
7
Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?在不影响治疗效果的前提下提高基于抗体的免疫调节癌症治疗的安全性:我们能否两全其美?
Expert Opin Biol Ther. 2016;16(5):655-74. doi: 10.1517/14712598.2016.1152256. Epub 2016 Feb 25.
8
Tumor-Unrelated CD4 T Cell Help Augments CD134 plus CD137 Dual Costimulation Tumor Therapy.肿瘤无关的CD4 T细胞辅助增强CD134加CD137双共刺激肿瘤治疗。
J Immunol. 2015 Dec 15;195(12):5816-26. doi: 10.4049/jimmunol.1502032. Epub 2015 Nov 11.
9
Is CD137 Ligand (CD137L) Signaling a Fine Tuner of Immune Responses?CD137配体(CD137L)信号传导是免疫反应的微调器吗?
Immune Netw. 2015 Jun;15(3):121-4. doi: 10.4110/in.2015.15.3.121. Epub 2015 Jun 25.
10
Substrate-dependent gene regulation of self-assembled human MSC spheroids on chitosan membranes.壳聚糖膜上自组装人 MSC 球体的底物依赖性基因调控。
BMC Genomics. 2014 Jan 5;15(1):10. doi: 10.1186/1471-2164-15-10.
高水平的共刺激受体 OX40 和 4-1BB 可作为急性冠状动脉综合征患者 CD4+CD28null T 细胞的特征。
Circ Res. 2012 Mar 16;110(6):857-69. doi: 10.1161/CIRCRESAHA.111.261933. Epub 2012 Jan 26.
4
Reverse signaling through the costimulatory ligand CD137L in epithelial cells is essential for natural killer cell-mediated acute tissue inflammation.上皮细胞中共刺激配体 CD137L 的反向信号对于自然杀伤细胞介导的急性组织炎症是必需的。
Proc Natl Acad Sci U S A. 2012 Jan 3;109(1):E13-22. doi: 10.1073/pnas.1112256109. Epub 2011 Dec 12.
5
Recombinant TAT-CD137 Ligand Cytoplasmic Domain Fusion Protein Induces the Production of IL-6 and TNF-α in Peritoneal Macrophages.重组 TAT-CD137 配体胞质结构域融合蛋白诱导腹腔巨噬细胞产生 IL-6 和 TNF-α。
Immune Netw. 2011 Aug;11(4):216-22. doi: 10.4110/in.2011.11.4.216. Epub 2011 Aug 31.
6
Deficiency for costimulatory receptor 4-1BB protects against obesity-induced inflammation and metabolic disorders.缺乏共刺激受体 4-1BB 可预防肥胖引起的炎症和代谢紊乱。
Diabetes. 2011 Dec;60(12):3159-68. doi: 10.2337/db10-1805. Epub 2011 Oct 13.
7
Host CD25+CD4+Foxp3+ regulatory T cells primed by anti-CD137 mAbs inhibit graft-versus-host disease.抗 CD137mAbs 诱导的宿主 CD25+CD4+Foxp3+调节性 T 细胞抑制移植物抗宿主病。
Biol Blood Marrow Transplant. 2012 Jan;18(1):44-54. doi: 10.1016/j.bbmt.2011.09.004. Epub 2011 Sep 28.
8
CD137 ligand, a member of the tumor necrosis factor family, regulates immune responses via reverse signal transduction.CD137 配体是肿瘤坏死因子家族的一员,通过反向信号转导调节免疫反应。
J Leukoc Biol. 2011 Jan;89(1):21-9. doi: 10.1189/jlb.0510315. Epub 2010 Jul 19.
9
CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice.CD137(4-1BB)缺乏可减少高脂血症小鼠的动脉粥样硬化。
Circulation. 2010 Mar 9;121(9):1124-33. doi: 10.1161/CIRCULATIONAHA.109.882704. Epub 2010 Feb 22.
10
CD137-CD137 Ligand Interactions in Inflammation.CD137-CD137 Ligand 相互作用与炎症。
Immune Netw. 2009 Jun;9(3):84-9. doi: 10.4110/in.2009.9.3.84. Epub 2009 Jun 30.